| Source: |
| Type: |
| Power to enhance an anti cancer effect |
| 5103- | SK, | Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor |
| - | in-vitro, | NSCLC, | A549 |
| 5101- | SK, | Shikonin induces colorectal carcinoma cells apoptosis and autophagy by targeting galectin-1/JNK signaling axis |
| - | vitro+vivo, | CRC, | SW-620 | - | vitro+vivo, | CRC, | HCT116 |
| 5100- | SK, | Shikonin-induced necroptosis in nasopharyngeal carcinoma cells via ROS overproduction and upregulation of RIPK1/RIPK3/MLKL expression |
| - | vitro+vivo, | NPC, | NA |
| 1344- | SK, | Novel multiple apoptotic mechanism of shikonin in human glioma cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | Hs683 | - | in-vitro, | GBM, | M059K |
| 2009- | SK, | Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer |
| - | in-vitro, | Bladder, | NA |
| 2008- | SK, | Cisplatin, | Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo |
| - | in-vitro, | CRC, | HCT116 | - | in-vivo, | NA, | NA |
| 2010- | SK, | Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway |
| - | in-vitro, | Lung, | H1975 | - | in-vitro, | Lung, | H1650 | - | in-vitro, | Nor, | CCD19 |
| 1281- | SK, | Enhancement of NK cells proliferation and function by Shikonin |
| - | in-vivo, | Colon, | Caco-2 |
| 4892- | Sper, | erastin, | Spermidine inactivates proteasome activity and enhances ferroptosis in prostate cancer |
| - | in-vitro, | Pca, | PC3 | - | in-vivo, | Pca, | NA |
| 4893- | Sper, | immuno, | Chemoproteomic Identification of Spermidine-Binding Proteins and Antitumor-Immunity Activators |
| - | in-vitro, | Var, | NA |
| 4896- | Sper, | immuno, | Spermidine potentiates anti-tumor immune responses and immunotherapy sensitivity in breast cancer |
| - | vitro+vivo, | BC, | NA |
| 5782- | Sper, | Cardioprotection and lifespan extension by the natural polyamine spermidine |
| - | in-vivo, | Nor, | NA |
| 5799- | Sper, | The positive effect of spermidine in older adults suffering from dementia : First results of a 3-month trial |
| - | Trial, | AD, | NA |
| 1512- | Squ, | Combination therapy in combating cancer |
| - | Review, | NA, | NA |
| 1706- | SSE, | Selenium in Prostate Cancer: Prevention, Progression, and Treatment |
| - | Review, | Pca, | NA |
| 1688- | SSE, | Potential Role of Selenium in the Treatment of Cancer and Viral Infections |
| - | Review, | Var, | NA |
| 1687- | SSE, | Selenium for preventing cancer |
| - | Analysis, | Var, | NA |
| 4739- | SSE, | Chemo, | Rad, | Therapeutic Benefits of Selenium in Hematological Malignancies |
| - | Review, | Var, | NA |
| 4727- | SSE, | Selenium inhibits ferroptosis in ulcerative colitis through the induction of Nrf2/Gpx4 |
| - | in-vivo, | Col, | NA |
| 4743- | SSE, | Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients |
| - | Review, | Var, | NA |
| 4728- | SSE, | Selective Impact of Selenium Compounds on Two Cytokine Storm Players |
| - | NA, | Covid, | NA |
| 4750- | SSE, | Rad, | Selenium in Radiation Oncology—15 Years of Experiences in Germany |
| - | Review, | Var, | NA |
| 5079- | SSE, | Rad, | The solvent and treatment regimen of sodium selenite cause its effects to vary on the radiation response of human bronchial cells from tumour and normal tissues |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | BEAS-2B |
| 5076- | SSE, | Sodium selenite inhibits the growth of cervical cancer cells through the PI3K/AKT pathway |
| - | in-vivo, | Cerv, | HeLa | - | in-vivo, | Cerv, | SiHa |
| 5075- | SSE, | Sodium selenite inhibits proliferation and metastasis through ROS‐mediated NF‐κB signaling in renal cell carcinoma |
| - | vitro+vivo, | RCC, | 786-O |
| 5091- | SSE, | Superoxide-mediated ferroptosis in human cancer cells induced by sodium selenite |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | CRC, | HT-29 | - | in-vitro, | Nor, | SVGp12 |
| 5093- | SSE, | Pharmacological mechanisms of the anticancer action of sodium selenite against peritoneal cancer in mice |
| - | in-vivo, | Var, | NA |
| 5111- | SSE, | Sodium selenite induces apoptosis via ROS-mediated NF-κB signaling and activation of the Bax-caspase-9-caspase-3 axis in 4T1 cells |
| - | in-vitro, | BC, | 4T1 |
| 5109- | SSE, | Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells |
| - | in-vitro, | CRC, | HCT116 |
| 5106- | SSE, | GSH, | Dual role of glutathione in selenite-induced oxidative stress and apoptosis in human hepatoma cells |
| - | in-vitro, | Liver, | HepG2 |
| 5105- | SSE, | Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells |
| - | in-vitro, | Pca, | LNCaP |
| 5095- | SSE, | Extracellular thiol-assisted selenium uptake dependent on the xc− cystine transporter explains the cancer-specific cytotoxicity of selenite |
| - | in-vitro, | Lung, | H157 |
| 5087- | SSE, | Sodium Selenite Alleviates Breast Cancer-Related Lymphedema Independent of Antioxidant Defense System |
| - | Trial, | BC, | NA |
| 5086- | SSE, | Sodium Selenite Induces Superoxide-Mediated Mitochondrial Damage and Subsequent Autophagic Cell Death in Malignant Glioma Cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | T98G | - | in-vitro, | GBM, | A172 |
| - | in-vitro, | NSCLC, | A549 |
| 112- | SuD, | Inhibition of Gli/hedgehog signaling in prostate cancer cells by “cancer bush” Sutherlandia frutescens extract |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP |
| 4151- | Taur, | Gins, | Taurine and Ginsenoside Rf Induce BDNF Expression in SH-SY5Y Cells: A Potential Role of BDNF in Corticosterone-Triggered Cellular Damage |
| - | in-vitro, | AD, | NA |
| 3960- | Taur, | Versatile Triad Alliance: Bile Acid, Taurine and Microbiota |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 3950- | Taur, | Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes |
| - | Review, | Diabetic, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
| 5332- | TFdiG, | Theaflavin-3,3′-digallate triggers apoptosis in osteosarcoma cells via the caspase pathway |
| - | vitro+vivo, | OS, | 143B | - | in-vitro, | OS, | U2OS |
| 5339- | TFdiG, | Pre-treated theaflavin-3,3′-digallate has a higher inhibitory effect on the HCT116 cell line |
| - | in-vitro, | CRC, | HCT116 |
| 113- | TQ, | Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer |
| - | vitro+vivo, | Pca, | C4-2B |
| 2353- | TQ, | The effects of thymoquinone on pancreatic cancer: Evidence from preclinical studies |
| - | Review, | PC, | NA |
| 2125- | TQ, | Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis |
| - | in-vitro, | RCC, | RCC4 | - | in-vitro, | RCC, | Caki-1 |
| 2123- | TQ, | Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma |
| - | in-vitro, | lymphoma, | PEL |
| 2121- | TQ, | Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROS |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
| 2120- | TQ, | Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3 |
| - | in-vitro, | Melanoma, | A431 |
| 2127- | TQ, | Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways |
| - | Review, | GBM, | NA |
| 2129- | TQ, | doxoR, | Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells |
| - | in-vitro, | BC, | MCF-7 |
| 2130- | TQ, | Thymoquinone Attenuates Brain Injury via an Anti-oxidative Pathway in a Status Epilepticus Rat Model |
| - | in-vivo, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:961 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid